85
50
Growth Score 85 in past quarter
-2 pts
Heat Score 50 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3912721
BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of
About the Company
BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of genes and gene expression, and genetic sequences of biological significance into a gene discovery, functional analysis, and identification of bio hazardous agents. It also utilizes its technology for target
validation, screening bio hazardous contamination, diagnostic applications, and prophylactic and therapeutic vaccine development. The company was founded in 2000 and is based in Gaithersburg, Maryland. As of February 12, 2008, BioAvenge operates as a subsidiary of GateKeeper USA, Inc. (OTCPK:GTKP).
